Abstract
Introduction
Epi de mio logy reveals a growing incide nce of vio lent cr ime co nc urrent with an incre ase in the use of highveloci ty wea po ns in our soc iety. In rece nt decades, gunshot wo unds (GS Ws) have accounted for an alar ming ly high percent age of traum a cases. Th e result s of this increase in violence are greate r mort alit y, morbidity, and neur otologic seq uelae. It is estimated that abo ut 38 ,000 Ame rica ns die fro m GS Ws eac h year. I By the end of th is ce ntury, it is estima ted that GSWs will surpass motor vehicle acci de nt inj uries as the leading cause of inj uryrelated mortal ity in the Uni ted States." Th e preva lence of GSWs and assoc iated head inj uries is part icul arl y high amo ng childre n and yo ung adults.r" Stud ies on cranial nerve injuri es and other neu rotologic co mplications associated with GSWs have been previously rep orted .' > Amo ng the neu rotolog ic co mplications of GSWs, the most common is fac ial ner ve paralysis. Facial nerve paral ysis is a significant indi cation for surgica l managem ent. " However, littl e is kno wn abo ut the nature and tim e co urse of facial nerve injury in GS W patient s. In emergency care, traum atic faci al paralysis is often ove rshadowed by life-threatening injuries that requi re more urgent care. Because few stud ies foc us on fac ial nerve impairme nt as a maj or ne uro to logic co mplication, little info rma tion is ava ilable for the eva luatio n and managem ent of fac ial ner ve compli cati ons in GSW patient s.
We co nducted elec tro diagnostic studies on 10 patients who ex per ienced un ilateral fac ial ner ve paralysis as a result of a GSW to characterize its neurotologic ma nifestations. We also report a co mpre he nsive case study on I patient to focu s attenti on on the eva luatio n offacia l ner ve injury during the co urse of GSW managem en t.
Materials and Methods

Subjects
Ten patients who had ear lier ex pe rience d a GSW that invo lved facial ner ve function we re se lec ted for this follow up study (table I; 
DIGITAL STROBE SETTING A NEW STANDARD
Kay' s Digital Strobe, an innovative digital video endoscopy/ stroboscopy system, sets a new standard for image quality and convenience for stroboscopy and endoscopy examination viewing and recording. With the Digital Strobe, patient exams are recorded directly to computer storage media. The resulting image quality is equivalent to professional broadcast standards, and superior to previous recording technology that relied on SVHS video recorders. Digitizing the video examination provides other benefits as well. Examinations can be located and viewed instantaneously without the need to rewind or fast forward to the start of the exam. In addition, two exams can be loaded and played side by side; this unique feature greatly facilitates exam comparisons.
The system is provided with a sophisticated patient database and a report generator which is automatically formatted as a Microsofi@ Word document ?he report includes patient information, a summary of key examination findings, still images, and an AVI video clip from the exam-this report can be printed or mailed electronically to colleagues and refemng physicians.
E
Patient exams are recorded directly to computer storage media.
Every component of the Digital Strobe has been carefully considered and integrated into a complete system for reliable, artifact-free video capture and playback. Current Kay stroboscopy customers can easily upgrade their systems to the new digital technology at an affordable price.
Kay' s stroboscopy systems complement a complete line of instrumentation fox the voice lab including the most widely used acoustic and aerodynamic analysis systems. Kay offers extensive product support that includes worldwide representatives, toll-free phone support, educational courses and workshops, and a comprehensive Web site. Electrodiagnos tic Test Battery. Bilateral electron eu rogra phy (ENo G) and facial electromyogra phy (EMG) were perform ed with the Spirit evoke d-potential system (Nic ole t Inc.; Madi son , Wi s.). Th e reco rding sys tem included amplifiers with a remo te preamplifie r and the S403 isolated electric stimulus prob e, which was conn ect ed to an isolated elec trica l stimulator box. Th e skin for placem ent of the elec tro des was carefully prep ared for optimal recordin g. Th e swee p veloc ities of the screen were 2 msf divis ion. Th e amplifier ga in was adj usted to betw een 400 and 500 uv/cm whe n the affe cted side was tested and between 500 and 1,000 IlVfcm when the normal side was tested. Details of the procedure hav e been descr ibed previ ou sly."
Facial EMG with surface electro des was per formed on all patients. In add ition, a faci al EMG with a concentric needl e elec trode was per form ed on I patient , a 39-yearold wom an (PL) whose GSW was sus pec ted of invol vin g the facial ner ve branches (see case report , below). Her needl e elec trode EMG assessed the sta tus of the four major faci al mu scles: the fro ntalis, the orbicu laris oc uli, the orbic ular is oris, and the depr essor anguli oris. Du rin g EMG, thi s wo ma n was aske d to perform different fac ial movem ent s, including closin g her eyes, puckerin g her mouth , depressin g her mouth, and wrinkling her forehead . EMG sig na ls were recorded at rest and during voluntary facial movem ent on both sides simultaneous ly. We ex pec ted th at the tested faci al muscle s would refl ect the function of the four maj or facia l nerve branches: the tem porofrontal, the zygo ma tic, the bucc al, and the mandibul ar.
Results
Of 39 cases of GSW to the head and neck that were treated at the LSUMC over a 4-year period , 10 (26%) involved faci al paralysis, and these pat ient s we re the focu s of this neuroph ysiolo gic study. According to the surgic al records and radiologic reports, the site of entry of these GSW s we re the periauri cular area in 5 pat ients, the face in 4 pat ient s, and the mandibl e in 1 patient. Fore ign oM. Speaking Volum • \Nhile most companies talk about their products, your patients will talk with VoCoM. The VoCoM System has been successfUly ,'rturning up the volume for patients with unilateral vocal cord paralysis around the world, with more than eight years of globa success stories -benefiting surgeons and patients alike. VoCoM offers surgeons rnaxirnurn flexibility, allowmq you to decide on the appropriate amount of displacement intraoperatively and to select the placement and orientation of the implant within the thyroid cartilage window. The dense hydroxylapatite composition ofVoCoM provides superior biocompatibility, another plus for both you and your patient. It's the product surgeons are talking aboutand the product patients are talking with. The VoCoM Vocal Cord Medialization System. 
Case Report
A 39-year-o ld black woman (PL) was seen 6 days after experiencing a sho tgun wound at close range to the left lower face. She was co nscious and cooperative during her examination . Her Glasgow coma scale score was 15, indicating good neurologic function. One day later she underwent exp loratory surgery to the left sty lomas toid foramen area for decompression of the injured fac ial nerve.
On exami natio n, there was a large laceration starti ng at the left commissure of the mo uth and extendi ng throu gh the left paroti d area and on to the infe rior pos tauricular area . The left side of her face was com pletely paralyzed. CT of the temporal bones revealed the presence of me tal fragments in the regio n of the stylomastoid fora men and a fract ure of the sty loid process, suggesting a likely direct injury to the facial nerve (figure 2) .
Pure-t one audiometry revealed a mild to modera te se nsori neural hear ing loss above 2,000 Hz in the left ear and normal hearing in the right ear (fig ure 3) . Th e acoustic reflex was abse nt in the left ear and within nor mal limits in the right ear, suggesting facial nerve invol vement to the proximal portion of the stapedial nerve. ENo G showe d no response on the left side, and facia l needle EMG found elect ric sile nce in the left mandibular, buccal, zygo matic, and temp orofront al branches (figure 4). On the left side, the fac ial mu scles exhibited no vo luntary motor unit potential and no abnor mal spo ntaneous acti vity (ie, no fibrillation or positive waves).Th e residual ac tivit ies see n on the recording were not related to any voluntary movement of the face ; rather, they were probab ly ge nera ted by the deep facia l muscles, which are not innervated by the facia l nerve.
At follow up I week later, repeat acoustic reflex and . 30 s bodies , including bull ets and bull et fragments, were found in all patie nts , Handguns were invo lved in 8 cases, and shotguns in 2 cases . Six of the I 0 patients ex pe rienced hematotyrn panum and bleeding in the external auditory canal. All patients repor ted some degree of hearing loss, ranging fro m mild to total and including mixe d and se nsori neural impairment (table I) . Six patien ts were co nfirmed by radiography to have temporal bone frac tures. Assessment of facia l function showe d that 7 patients had grade VI function (total paralysis), 2 had gra de III function, and I had grade II func tio n.
The time course of fac ial function in these patients was found to be different from that see n in patients with Bell's palsy. Spec ifically, ENoG resu lts in GSW patie nts were better than the facia l grading resu lts after the firs t week, but thereaft er they became worse. The prognosis for the 10 patients was generally poor, as determined by seria l tes ting with ENoG and facia l grad ing. Six patien ts with grade VI facia l functio n on initial testing experienced a poor recovery, improvi ng no further tha n grade III duri ng the 2 to 18 months of follow up. Figure I shows the CT findings in a 2 1-yea r-o ld man (MT) who ex perienced a GSW to the left temporal bone. The bone was fragmented around the petrou s area . The patient suffered a complete fac ial paralysis and total hearing loss. Fo ur patients with tota l facial nerve paralysis were referred for surg ical exp loration, and the other2 were treated with wound closure on ly. • "Zeiss UpJJ your operating room. pression and concu ssion-as we see in the case of the woman describ ed in the case report of this study.
The study of facial function in this investigati on , as mea sured by repeat ENoG and videotape facial grading, illustrated the characteristic pattern of traumatic paralysis. Such a pattern is different from the pattern s manifested in Bell' s palsy." For example, patient s with complete unilateral faci al paralysis due to traum a may experien ce a significant impr ovem ent in 3 to 7 days, only to see the paralysis return I or 2 weeks later and persist for severa l month s there after.
Mak ing a timely and objective eva luation of a traum atic fac ial nerve injury associated with a GSW is quite ch allen gin g. For exampl e, durin g the acute stage , the presence of swe lling and sutures makes it difficult to'find a goo d site to attac h electrodes . But at the very least, facia l gra ding via video tape should be undertaken and document ed . CT is most valuable in eva luating a temporal bone frac ture and its assoc iation with facia l nerve paralySiS. 13 Aco ustic immittance testing is also valuable for eva luating middl e ear and fac ial ner ve functions. Patients who hav e a clear external canal and middl e ear sho uld undergo acoustic reflex testin g to ev aluate both the ce ntral and peripheral portions of the facial nerve, from the brain stem to the stapedial branch of the nerve . The pres-~.
'~.~~~+'-1~H ENoG test results showe d similar findings. By the week-3 followup, the aco ustic reflex had esse ntially returned to normal, but the ENoG still showe d no response on the left side. Th ese findings sugges t that the patient' s facial paralysis was primarily the result of I) trauma to the area of the sty10-mastoid foramen and 2) edema or inflammation extending to the more proximal portion of the facial ner ve as a result of concu ssion . The woman eventually recovered (table 2) .
Discussion
Facial nerve paralysis has been documented as one of the major neurotologic sequelae associ ated with gunshot-related head injuries. Haberkamp et al reported that 75% of patien ts with GSW s to the temporal bone experienced facial nerve paralysis.' Such paralysis is classified as either complete or incompl ete and reversible or permanent. The causes of facial nerve imp airm ent follow ing GSW s are remark ably different from those seen after other penetrating or blunt traum atic inj uries." !" In cas es of GSW , the direct injury to the facial nerve is straightforward. Moreover, GSWs often invo lve the face, middle ear, and temporal bone , and they often transect the facial nerve with highly variabl e degrees of severity. Other penet rating or blunt trauma injurie s usually cau se less damage to the bone and soft tissue.
The degree and extent of facial nerve injury from a gunshot are somewhat related to the size, velocity , and power of the bullet or shell, but they are primarily dependent on the anatomi c locati on of the wound . A most commo n cau se of facial paralysis following a GSW is a fragmented fracture of the temp oral bone. Our study found that all 7 GSW patient s who had sustained a fracture to the temp oral bone and mastoid subsequently develop ed complete unilateral facial paralysis. There are many types of tempora l bone fracture seco ndary to GSW s. The spec ific grav ity of the temp oral bone makes it more vulnerable than other body components to shatteri ng and splintering. When a missile strikes the temp oral bone, the frag ments and shock waves can cause a fractureor severe co ncussion of the temp oral bone and cause dama ge to the middl e cranial fossa, the facial nerve, and the cochlea.II The y can also cause tissue frag mentation and bone cavitation.
The co mplications of an injury by a bull et that penetrates the temporal bone are different from tho se that result from penetration of the so ft tissue. " In addition, a GSW may also cau se a combined direct injury-com- ence of an acoustic reflex indica tes that the inj ury site is dista l to the staped ial branch ; it also suggests that the injury is localized, affording easy access for surgical exploration.
When there is no aco ustic reflex, interpretatio n is more difficult. If CT or magne tic reso nance imagi ng shows no ev idence of facia l nerve involvement and if tympanometry revea ls norma l middle ear function despi te poor facial function, seria l testing of the acous tic reflex should be performed. For example, the GSW in the woma n descri bed in the case report involved the sty lomastoid foramen, but she init ially exhi bited an abse nce of the aco ustic reflex. The aco ustic reflex returned to normal 2 weeks later, despi te her tota l facia l paralysis. The woman also had a mild to moderate sensorineural hearing loss at the high freq uencies, which reso lved somewhat over the followi ng 4 to 6 weeks . Ser ial testing also demonstrated a normal level of evoked otoacoustic em issio ns, whic h suggests normal coc hlear func tion. Audi tory bra inste m response revealed normal latencies of III and Y, with a slightly delayed wave I. Thu s, the injury that cause d the sensorineural hearing loss is likely to be within the auditory nerve . Th is unique case illustrates the reversible nature of an inj ury to the facia l nerve proxi mal to the stylomastoid forame n.
This study also demonstrates that there is a high incidence of hearing loss associated wit h traumatic fac ial nerve paralysis .Therefore, an audiologic evaluation should be routinely included in the work up of all patients who incur a GSW to the head or neck. This is part icularly important in ch ildre n because any auditory sequelae may 278 interfere with thei r speech and language development. Repeat audio logic eva luation is usua lly necessary to assess middle ear sta tus and hearing sens itivity. Clinicians should search for the nature of any persistent hearing loss 4 to 6 weeks after the injury was incurred .
The management of faci al paralysis follow ing a GSW begins with the ge nera l principles of emergency care, including clearing the airway and contro lling bleed ing." Most cases of simple ear injury or tempora l bone concussion can be managed by simple obse rvation whe n radiograp hic and neur otologic find ings are negative. When post-GSW facia l paral ysis does not spon taneo usly resolve as measured by facia l ENoG or EMG, exp lorat ion and nerve repair sho uld be performed as soon as prac ticab le, prefera bly wit hin 4 to 6 weeks of the inj ury. Exp lora tion of extracrania l pene trating wou nds should be undertaken cau tio usly. Preoperative arter iography may be useful for a patient with a GSW to the tem poral bone area to look for possible inj ury to the intern al caro tid artery , sigmo id sinus, and j ugular bulb. Frag me nts of skin and bone in the externa l cana l, midd le ear, mastoid, and petrous bone should be debrided to prevent infection and cholesteatoma for matio n.
Because facia l paralysis is often associated with a GSW in the temp oral bo ne, the surgical option of choice is a transmastoid procedur e.IS The rea nimation proce dure performed at the LSUMC incl udes nerve grafting and a hy poglossa l nerve hooku p or cros sover. Whe n a GSW is con tamina ted or infec ted, the proximal and dis tal ends of the facia l nerve should be connec ted by a nonabsorbable, eas ily identifia ble suture and followed up wit hin 30 days .IS The followi ng treatment-related adverse events were each reported in a single subject: dermatitis, eczema, erythematous rash, follicular rash, rash, hypoaesthesia, tinnitus, dyspepsia, hot flushes, lIushing, and otorrhagia.
Subjects with Acute Otitis Media with Tympanostomy Tubes and Subjects with Chronic Suppurative Otitis Media with Perforated Tympanic Membranes
The following treatment-related adverse events occurred in 1% or more of the subjects with non-intact tympanic membranes.
of 810 mglkg/day. Ofloxacin has not been shown to be teratogenic at doses as high as 810 mglkg/day and 160 mglkg/day when administered to pregnant rats and rabbits, respectively. Olloxacin has not been shown to have any adverse effectson the developing embryo or fetus at doses relevant to the amount of olloxacin that will be delivered ototopically at the recommended clinical doses. Nonteratogenic Effects: Additional studies in the rat demonstrated that doses up to 360 mglkg/day during late gestation had no adverseeffects on late fetal development, labor,delivery, lactation, neonatal viability, or growth of the newborn. There are, however, no adequate and well-eontrolled studies in pregnant women. FLOXIN" Otic should be used during preg· nancy only if the potential benefit justifies the potential risk to the fetus. Nursing Mothers: In nursing women, a single 200 mg oral dose resulted in concentrations of ofloxaci n in milk which were similar to those found in plasma. It is not known whetherolloxacin is excretedin humanmilk following topical otic administration. Because of the potential for serious adversereactions from olloxacin in nursinginfants, a decision should be madewhetherto discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. Pediatric Use: No changes in hearing function occurred in 30 pediatric subjects treated with olloxacin otic and tested for audiometric parameters. Although safety and efficacy have been demonstrated in pediatric patients one year and older, safety and effectivenessin infantsbelow the age of one year have not been established. Although quinolones, inclUding olloxaci n, have been shown to cause arthropathy in immature animals after systemic administration, young' growing guinea pigs dosed in the middle ear with 0.3% ofloxacin otic solution for one month showed no systemic effects, quinolone·induced lesions, erosions of the cartilage in weight· bearing joints, or other signs of arthropathy. ADVERSE REACTIONS In the Phase III registration trials, a total of 885 subjectswere treated with ofloxaci n otic solution: This included 229 subjectswith otitis externa(with intact tympanic membranes) and 656 subjects with acute otitis media with tympanostomy tubes or chronic suppurative otitis mediawith perforated tympanic membranes. The reported treatment-rel ated adverse events are listed below:
Subiects with Otitis Externa The followi ng treatment-related adverse events occurred in 1% or more of the subjects with intact tympanic membranes.
Other treatment-related adverse reactions reported in subjects with non-intact tympanic membranes included: diarrhea (0.6%), nausea (0.3%), vomiting (0.3%), dry mouth (0.5%), headache (0.3%), vertigo (0.5%), otorrhagia (0.6%), tinnitus (0.3%), fever (0.3%). The following treatment-related adverse events were each reported in a single subject: application site reaction, otitis externa, urticaria, abdominal pain, dysaesthesia, hyperkinesia, halitosis, inflammation, pain, insomnia, coughing, pharyngitis, rhinitis, sinusitis, and tachycardia. DOSAGE AND ADMINISTRATION Otitis Externa: The recommended dosage regimen for the treatment of otitis externa is: For pediatric patients (from 1 to 12 years old): Five drops (0.25 mL, 0.75 mg olloxacin) instilled into the affected ear twice daily for ten days. For patients 12 years and older:Ten drops (0.5 mL, 1.5 mg ofloxacin) instilled into the affected ear twice daily for ten days. The solution should be warmed by holding the bottle in the hand for one or two minutes to avoi d dizziness which may result from the Instillation of a cold solution. The patient should lie with the affected ear upward, and then the drops should be instilled. This position should be maintained for five minutes to facilitate penetration of the drops into the ear canal. Repeat, if necessary, for the opposite ear. Acute Otitis Media in pediatric patients with tympanostomy tubes : The recommended dosage regimen forthe treatment of acute otitis media in pediatric patients (fromone to12years old) with tympanostomy tubes is: Five drops (0.25 mL, 0.75 mg olloxacin) instilled into the affected ear twice daily for ten days. The solution should be warmed by holding the bottlein the hand for one or two minutes to avoid dizzness which may result from the instillation of a cold solution.The patient should lie with the affected ear upward, and then the drops shouldbe instilled.The tragus should then be pumped 4 times by pushing inward to facilitate penetration of the drops into the middle ear. This position should be maintained for five minutes. Repeat, if necessary, for the oppositeear. Chronic Suppurative Otitis Media with perforated tymp anic membranes : The recommended dosage regimen for the treatment of chronic suppurative otitis media with perforated tyml'.anic membranes in patients 12 years or older is: Ten drops (0.5 mL, 1.5 mg ofloxacin) instilledinto the affected ear twice daily for fourteen days. The solutionshoul d be warmed by holding the bottle in the hand for one or two minutesto avoid dizziness which may result from the instillat ion of a cold solution.The patient should lie with the affectedear upward, before instilling the drops.The tragus should then be pumped 4 times by pushing inward to facilitate penetration into the middle ear.This position shoul d be maintained for five minutes. Repeat, if necessary, for the opposite ear. The systemic administration of quinolones, including olloxacinat doses muchhigherthan given or absorbed by theotic route, has led to lesionsor erosions of the cartilage in weight-bearing joints andothersignsof arthropathy in immature animalsof various species, Young growing guineapigs dosed in the middle ear with 0.3% ofloxacin otic solution showed no systemic effects, lesionsor erosions of the cartilage in weight-bearing joints, or other signs of arthropathy. No drug-related structural or functionalchanges of the cochlea and no lesions in the ossicles were notedin the guinea pig following otic administration of 0.3% ofloxacin for one rnomh, No signsof localirritation were found when 0.3% olloxacin was applied topically in the rabbit eye. Olloxacin was also shown to lack dermal sensitizing potential in the guinea pig maximization study . Information for Patients: Avoi d contaminating the applicator tip with material from the fingers or other sources. This precaution is necessary if the sterility of the drops is to be preserved. Systemic quinolones, incl uding olloxacin, have been associated with hypersensitivity reactions, even followi ng a singledose. Discontinue use immediately and contact your physici an at the first sign of a rash or aller gic reaction. Otitis Externa Prior to administra tion of FLOXIN" Otic in patients with otitis externa, the solution should be warmed by holdingthe bottle in the hand for one or two minutes to avoid dizziness which may result fromthe instillation of a cold solution. The patient should lie with the affected ear upward, and then the drops should be instilled. This position should be maintained for five minutes to facilitate penetration of the drops into the ear canal. Repeat. if necessary,for the opposite ear (see DOSAGE ANDADMINISTRATION). Acute Otitis Media and Chronic Suppurativ e Otitis Media In pediatric patients (from 1 to 12 years old) with acute otitis media with tympanostomy tubes and in patientswith chronic suppurativeotitis media with perforated tympanic membranes, prior to admi nistration, the solutionshould be warmed by holding the bottle in the hand for one or two minutes to avoi d dizziness which may result from the Instillation of a cold solution, The patient should lie with the allected ear upward, and then the drops should be instilled. The tragus should thenbe pumped 4 times by pushing inward to facilitate penetration of the drops into the middle ear. This position should be maintained for five minutes, Repeat, if necessary, for the opposite ear (seeDOSAGEAND ADMINISTRATION)_ Drug Interactions: Specific drug interaction studies have not been conducted with FLOXIN" Otic, Carcinogenesis, Mutagenesis, Impairment of Fertility Long-term studies to determine the carcinogenic potential of ofloxacln have not been conducted. Olloxacinwas not mutagenic in the Ames test, the sister chromatidexchangeassay (Chinesehamsterand human cell lines), the unscheduled DNA synthesis (UDS) assay using human fibroblasts, the domi nant lethal assay, or the mouse micro-nucleus assay. Olloxacin was positive in the rat hepatocyteUDS assay, and in the mouse lymphoma assay. In rats, ofloxacin did not affect male or female reproductive performance at oral doses up to 360 mglkg/day. This would be over 1000 times the maximum recommended clinical dose, based upon body surface area, assumingtotal absorption of otloxacin from the ear of a patient treated with FLOXIN" Otic twice per day. Pregnancy Teratogenic effects: Pregnancy Category C. Ofloxacinhas been shown to have an embryocidal effectin ratsat a dose of 810 mglkg/day and in rabbits at 160 mglkg/day. These dosagesresulted in decreased fetal body weights and increased fetal mortality in rats and rabbits, respectively. Minor fetal skeletal variations were reported in rats receiving doses Most commonly reported adverse reactions in clinical trials in patients treated with FLOXIN Otic: otitis externa patients (n=229), pruritus (4%), application site reaction (3%), dizziness (1 %), earache (1 %) and vertigo (1%); acute otitis media patients with tympanostomy tubes and chronic suppurative otitis media patients with perforated tympanic membranes (n=656), taste perversion (7%), earache (1 %), pruritus (1 %), paraesthesia (1%), rash (1%) and dizziness (1%). FLOXIN Otic is contraindicated in patients with a history of hypersensitivity to ofloxacin, other quinolones, or other ingredients of the medication, and should be discontinued at the first sign of allergic reaction. Patients who have not improved after one week of treatment should be evaluated bytheir doctor. 
NEUROTO LOG IC EVALUATION OF FACIAL NERVE PARALYSIS CAUS ED BY GUNSHOT WOUNDS
